System for screening cells for high expression of a protein of interest (POI)

Details for Australian Patent Application No. 2006283844 (hide)

Owner Laboratoires Serono S.A.

Inventors Kobr, Michel; Dupraz, Philippe

Agent Griffith Hack

Pub. Number AU-A-2006283844

PCT Pub. Number WO2007/023184

Priority 60/714,500 06.09.05 US; 05018634.5 26.08.05 EP

Filing date 25 August 2006

Wipo publication date 1 March 2007

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023184 Priority application(s): WO2007/023184

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283846-Pyrazine derivatives and use as PI3K inhibitors

2006283842-Delta and epsilon crystal forms of imatinib mesylate